Post-earnings recap
Reported
Thu, Nov 7, 2013
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bio Rad Laboratories reported a loss per share that was significantly below expectations, indicating challenges in their operations. Despite this, the stock saw a slight increase of 0.76%, which may reflect investor optimism about the company's long-term strategies. The lack of revenue data and guidance leaves some uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.25 | N/A | -137.88% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed caution regarding the current economic climate. They remain committed to strategic initiatives aimed at future growth.
Management acknowledged challenges in the current market environment.
They emphasized a focus on long-term growth despite short-term setbacks.